Brands in demand: Keytruda, Dupixent and Ozempic lead 2023 new sales predictions — Evaluate report
What’s old is new again for 2023 when it comes to pharma drug brands added sales this year. Led by Merck’s Keytruda and Sanofi and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.